Outcomes in patients with multiple myeloma with TP53 deletion after autologous hematopoietic stem cell transplant. [electronic resource]
Producer: 20170525Description: E442-7 p. digitalISSN:- 1096-8652
- Adult
- Aged
- Disease Progression
- Disease-Free Survival
- Female
- Gene Deletion
- Hematopoietic Stem Cell Transplantation -- methods
- Humans
- Immunologic Factors -- therapeutic use
- Male
- Middle Aged
- Multiple Myeloma -- genetics
- Proteasome Inhibitors -- therapeutic use
- Recurrence
- Survival Analysis
- Transplantation, Autologous
- Treatment Outcome
- Tumor Suppressor Protein p53 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.